CPT code 33894 represents a minimally invasive endovascular procedure in which a stent is placed across one or more major side branches of the aorta to treat coarctation, a congenital narrowing that can impair systemic blood flow. The code captures a specialized interventional cardiology or vascular surgery service that carries implications for procedural planning, device selection, and site-of-service billing. Nationally, use of this code signals access to catheter-based treatments for congenital aortic disease and affects payment policy and device coverage decisions.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and service settings, and will learn what benchmarks and policy considerations typically relate to this type of high-acuity vascular intervention. The publication outlines coding definitions, common modifiers, and payer coverage patterns where available, and provides guidance on where to look for reimbursement and prior authorization policy updates. Data not available in the input is explicitly noted where applicable.